121 related articles for article (PubMed ID: 65893)
1. Effect of encephalitogenic protein on migration in agarose of leukocytes from patients with multiple sclerosis. Variable effect of the antigen in a large dose range, with a literature review.
Källén B; Nilsson O; Thelin C
Acta Neurol Scand; 1977 Jan; 55(1):33-46. PubMed ID: 65893
[TBL] [Abstract][Full Text] [Related]
2. Effect of encephalitogenic protein on migration in agarose of leukocytes from patients with multiple sclerosis. A longitudinal study of patients with relapsing multiple sclerosis or with cerebral infarction.
Källén B; Nilsson O; Thelin C
Acta Neurol Scand; 1977 Jan; 55(1):47-56. PubMed ID: 65098
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte migration in agarose, a study on multiple sclerosis.
Bergstrand H; Källén B; Nilsson O
Acta Allergol; 1975 Jul; 30(2-3):150-66. PubMed ID: 50704
[TBL] [Abstract][Full Text] [Related]
4. Delayed hypersensitivity to human encephalitogenic protein as assayed by agarose leucocyte migration in multiple sclerosis patients.
Clanet M; Kuhlein E; Rascol A; Abbal M; Ohayon E
J Neurol Sci; 1979 Jul; 42(2):203-13. PubMed ID: 90126
[TBL] [Abstract][Full Text] [Related]
5. Effect of encephalitogenic protein on the migration in agarose of leucocytes from patients with multiple sclerosis. Correlations with clinical parameters, localization of antigenic determinants, and influence of corticotrophin treatment.
Berg O; Bergstrand H; Kllén B; Nilsson O
Acta Neurol Scand; 1975 Oct; 52(4):303-18. PubMed ID: 53988
[TBL] [Abstract][Full Text] [Related]
6. Effect of encephalitogenic protein on migration in agarose of leukoytes from patients with multiple sclerosis. A longitudinal study of patients with relapsing multiple sclerosis or with cerebral infarction.
Källen B; Nilsson O; Thelin C
Acta Neurol Scand; 1977 Jan; 55(1):47-56. PubMed ID: 65894
[TBL] [Abstract][Full Text] [Related]
7. Effect of basic encephalitogenic protein and some peptides derived from it on the migration in agarose gel of leukocytes from patients with multiple sclerosis, other neurological diseases, or carcinoma.
Bergstrand H; Källén B; Nilsson O
Acta Neurol Scand; 1974; 50(2):227-47. PubMed ID: 4134200
[No Abstract] [Full Text] [Related]
8. [Leukocyte migration inhibition test in multiple sclerosis - results of a migration technic according to Clausen using brain specific antigens].
Lehmitz R; Meyer-Rienecker HJ; Werner H; Eichler R
Psychiatr Neurol Med Psychol (Leipz); 1980 Oct; 32(10):577-87. PubMed ID: 6164068
[TBL] [Abstract][Full Text] [Related]
9. Cellular immunity to encephalitogenic protein in multiple sclerosis. Correlations with other laboratory characteristics at different disease courses.
Nilsson O; Thelin C
Eur Neurol; 1977; 16(1-6):247-56. PubMed ID: 79488
[TBL] [Abstract][Full Text] [Related]
10. Effect of encephlitogenic protein. PPD and tetanus toxoid on leukocyte migration in agarose. A study of "cross-reactivity".
Källén B; Nilsson O
Allergy; 1979 Apr; 34(2):97-102. PubMed ID: 89821
[TBL] [Abstract][Full Text] [Related]
11. Cell-mediated hypersensitivity in multiple sclerosis and other neurological diseases.
Minderhoud JM; Mourik J; Teelken AW
Clin Neurol Neurosurg; 1977; 80(1):22-32. PubMed ID: 73438
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of active E-rosette forming lymphocytes by myelin basic protein and specific antigens from multiple sclerosis brains.
Offner H; Rastogi SC; Konat G; Clausen J
J Neurol Sci; 1979 Aug; 42(3):349-55. PubMed ID: 92529
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis: sensitization of a myelin basic protein fragment (peptide T) encephalitogenic to primates. A preliminary report.
Sheremata W; Eylar EH; Cosgrove JB
J Neurol Sci; 1977 Jun; 32(2):255-63. PubMed ID: 69018
[TBL] [Abstract][Full Text] [Related]
14. Age-related reactivity of lymphocytes from multiple sclerosis patients to myelin basic protein.
Wicher V; Olszewski W; Milgrom F
Int Arch Allergy Appl Immunol; 1981; 66(2):136-41. PubMed ID: 6169648
[TBL] [Abstract][Full Text] [Related]
15. Short-term evolution of autoreactive T cell repertoire in multiple sclerosis.
Vergelli M; Mazzanti B; Traggiai E; Biagioli T; Ballerini C; Parigi A; Konse A; Pellicanò G; Massacesi L
J Neurosci Res; 2001 Nov; 66(3):517-24. PubMed ID: 11746371
[TBL] [Abstract][Full Text] [Related]
16. Relation of measles virus to encephalitogenic factor with reference to the aetiopathogenesis of multiple sclerosis.
McDermott JR; Field EJ; Caspary EA
J Neurol Neurosurg Psychiatry; 1974 Mar; 37(3):282-7. PubMed ID: 4133588
[TBL] [Abstract][Full Text] [Related]
17. Suppressed lymphoblastic response to myelin basic protein of lymphocytes from patients with multiple sclerosis.
Wicher V; Olszewski W; Milgrom F
Int Arch Allergy Appl Immunol; 1979; 59(1):49-57. PubMed ID: 87376
[No Abstract] [Full Text] [Related]
18. Specificity of antibody-dependent lymphocyte cytotoxicity against cerebral tissue constituents in multiple sclerosis. Studies with basic protein of myelin, encephalitogenic peptide, cerebrosides and gangliosides.
Frick E; Stickl H
Acta Neurol Scand; 1982 Jan; 65(1):30-7. PubMed ID: 6175158
[TBL] [Abstract][Full Text] [Related]
19. Optic neuritis and multiple sclerosis. Cell-mediated cytotoxicity by peripheral blood lymphocytes against basic protein of myelin, encephalitogenic peptide, cerebrosides and gangliosides.
Frick E
Eur Neurol; 1988; 28(3):120-5. PubMed ID: 2454817
[TBL] [Abstract][Full Text] [Related]
20. Direct leukocyte migration inhibition in multiple sclerosis--a possible assessment of activity.
Day MP; Day JH; Mann PL
Can J Neurol Sci; 1976 May; 3(2):99-103. PubMed ID: 1268769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
